Metrics to compare | 301331 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship301331PeersSector | |
|---|---|---|---|---|
P/E Ratio | 43.2x | 20.1x | −0.4x | |
PEG Ratio | 16.43 | 0.26 | 0.00 | |
Price/Book | 1.9x | 2.3x | 2.6x | |
Price / LTM Sales | 2.4x | 3.2x | 3.0x | |
Upside (Analyst Target) | - | 26.0% | 52.8% | |
Fair Value Upside | Unlock | 17.7% | 9.7% | Unlock |
Enwei Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of Chinese medicines and chemical drugs in China. The company offers drugs in the areas of gynecology, pediatrics, respiratory, stomatology, digestive, cardiovascular, hepatobiliary, and dermatology under the Jieeryin, Haowayou, and Likeshu brands. It also provides products for cold and fever relief, dental care, warming/nourishing/tonic purposes, and other uses; ointments, suppositories, capsules, effervescent tablets, and antibacterial washes; hygiene products, disinfectants, medical devices, pharmaceutical packaging materials and containers, and daily chemical products; compound preparations, oral liquids and solutions, syrups, and decoctions; and tablets, granules, powders, large honey and water pills, water-honey and concentrated pills, wax pills, and syrups. In addition, the company engages in medical research and experimental development. Enwei Pharmaceutical Co., Ltd. was founded in 1986 and is based in Chengdu, China.